The final episode of this season of What’s Your Why is a special one, as Hannah and Mike sat down with our sponsors, Curaleaf Laboratories.

Brothers Jonathan and Richard Hodgson co-founded Rokshaw Laboratories in 2012 and have been at the forefront of the emerging medical cannabis Industry since it was first legalised as a medicine in 2018.

In 2019, Rokshaw joined the Curaleaf International group—the world’s largest cannabis company— where Jonathan is now International Managing Director for the UK and Nordics and Richard is UK Operations Director. As a result of this, in August 2020, Rokshaw became the first company to manufacture medical cannabis in the UK and another of its UK operations, Sapphire Medical Cannabis Clinic (now Curaleaf Clinic) was the first CQC Registered Medical Cannabis Clinic.

Having been in the healthcare sector since 1999 across a number of leading companies Jonathan and Richard have a clear number one position in this rapidly growing sector and have aligned with the Curaleaf mission, to provide wider access and unlock the potential of medical cannabis to those who need it.

In this episode they share some behind the scenes insights into the early days of starting the company, the challenges they faced (and continue to face) in the sector, and the realities of running a family business.

A quick thank you to our sponsors:

This episode What’s Your Why podcast is sponsored by Curaleaf Laboratories.

Curaleaf Laboratories are the UK-leading experts in the manufacture and distribution of EU-GMP medical cannabis as part of Curaleaf International, the biggest cannabis company in the world.

In 2019, Rokshaw joined the Curaleaf International group and because of this, in August 2020, became the first manufacturer of full spectrum medical cannabis in the UK. We aligned with the Curaleaf mission, to provide wider access and unlock the potential of medical cannabis to those who need it.

With over a decade of experience in unlicensed medicines (Specials), Curaleaf have invested heavily in our state-of-the-art UK manufacturing facility, making us perfectly positioned with our international vertically integrated supply chain to deliver cannabis-based medicinal products (CBPM’s) of the highest quality for specialists to prescribe to their patients.

Curaleaf’s wealth of medical cannabis experience, combined with a network of supply and distribution partnerships throughout Europe and the UK, mean that it is uniquely positioned to meet the rapidly growing demand for cost-effective, consistent, premium quality medical cannabis products in the UK.

Find out more at curaleaflaboratories.co.uk

Hosted on Acast. See acast.com/privacy for more information.